PCK1 and steatosis: Mechanistically, loss of PCK1 not only promotes steatosis by enhancing lipid deposition, but also induces fibrosis through HSC activation via paracrine secretion of PDGF-AA, thus promoting MAFLD progression (Fig. 8h).